{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:54:10Z","timestamp":1792929250636,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bcp.2007.08.007","type":"journal-article","created":{"date-parts":[[2007,8,10]],"date-time":"2007-08-10T18:08:36Z","timestamp":1186769316000},"page":"2-16","source":"Crossref","is-referenced-by-count":81,"title":["Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction"],"prefix":"10.1016","volume":"75","author":[{"given":"Richard B.","family":"Rothman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Prisinzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bcp.2007.08.007_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrd896","article-title":"Drug addictions: towards socially accepted and medically treatable diseases","volume":"1","author":"Pouletty","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.bcp.2007.08.007_bib2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nn1105-1429","article-title":"The neuroscience of addiction","volume":"8","author":"Volkow","year":"2005","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.bcp.2007.08.007_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.bcp.2007.08.007_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nrn1539","article-title":"Drug addiction: the neurobiology of behaviour gone awry","volume":"5","author":"Volkow","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.bcp.2007.08.007_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bcp.2007.08.007_bib6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0006-3223(98)00123-1","article-title":"Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans","volume":"44","author":"Baumann","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.007_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vph.2005.08.030","article-title":"Noradrenaline is necessary for the hedonic properties of addictive drugs","volume":"45","author":"Jasmin","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.007_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02740680","article-title":"A review of the effects of dopaminergic agents on humans, animals and drug seeking behavior, and its implications for medication development: focus on GBR12909","volume":"11","author":"Rothman","year":"1995","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ajp.156.1.11","article-title":"Limbic activation during cue-induced cocaine craving","volume":"156","author":"Childress","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.bcp.2007.08.007_bib11","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1176\/appi.ajp.159.10.1642","article-title":"Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex","volume":"159","author":"Goldstein","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bcp.2007.08.007_bib12","first-page":"169","article-title":"Addiction","volume":"vol. 6","author":"Newman","year":"2007"},{"issue":"8","key":"10.1016\/j.bcp.2007.08.007_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1360-0443.2002.00209.x","article-title":"Pharmacological treatment of cocaine dependence: a systematic review","volume":"97","author":"de Lima","year":"2002","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.bcp.2007.08.007_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/med.10014","article-title":"Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic\u2014a focus on analogues of benztropine and rimcazole","volume":"22","author":"Newman","year":"2002","journal-title":"Med Res Rev"},{"issue":"10","key":"10.1016\/j.bcp.2007.08.007_bib16","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1021\/jm030092d","article-title":"2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy","volume":"46","author":"Carroll","year":"2003","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib17","first-page":"47","article-title":"Development of neurochemical normalization (\u201cagonist substitution\u201d) therapeutics for stimulant abuse: focus on the dopamine uptake inhibitor, GBR12909","volume":"4","author":"Prisinzano","year":"2004","journal-title":"Curr Med Chem (CNSA)"},{"issue":"8","key":"10.1016\/j.bcp.2007.08.007_bib18","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2007.08.007_bib19","doi-asserted-by":"crossref","first-page":"PL17","DOI":"10.1016\/0024-3205(90)90466-5","article-title":"High affinity dopamine reuptake blockers as potential cocaine antagonists: a strategy for drug development","volume":"46","author":"Rothman","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2007.08.007_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-5793(89)81566-2","article-title":"Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development","volume":"257","author":"Rothman","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2007.08.007_bib21","first-page":"363","article-title":"Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake","volume":"15","author":"Van der Zee","year":"1980","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bcp.2007.08.007_bib22","first-page":"241","article-title":"Vanoxerine National Institute on drug abuse","volume":"1","author":"Preti","year":"2000","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.bcp.2007.08.007_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","article-title":"The dopamine uptake inhibitor GBR12909: selectivity and molecular mechanism of action","volume":"166","author":"Andersen","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.007_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0197-0186(89)90140-X","article-title":"Comparative properties of the dopamine transport complex in dog and rodent brain: striatal [3H]GBR12935 binding and [3H]dopamine uptake","volume":"15","author":"Sharif","year":"1989","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bcp.2007.08.007_bib25","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/j.1471-4159.1987.tb05752.x","article-title":"Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex","volume":"48","author":"Andersen","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2007.08.007_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1254\/jjp.55.501","article-title":"Characteristics of the ambulation-increasing effect of GBR-12909, a selective dopamine uptake inhibitor, in mice","volume":"55","author":"Hirate","year":"1991","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.007_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(87)90603-0","article-title":"Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat","volume":"135","author":"Westerink","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2007.08.007_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0091-3057(91)90570-R","article-title":"GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine","volume":"40","author":"Rothman","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.007_bib29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0091-3057(92)90493-Y","article-title":"Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter","volume":"43","author":"Rothman","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.007_bib30","first-page":"1216","article-title":"GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat","volume":"271","author":"Baumann","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.007_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1037\/1064-1297.3.3.232","article-title":"Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II: comparisons with other drugs and repeated administrations","volume":"3","author":"Glowa","year":"1995","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.bcp.2007.08.007_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0014-2999(89)90447-0","article-title":"Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat","volume":"167","author":"Kelley","year":"1989","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2007.08.007_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002130050054","article-title":"Cocaine-induced changes in extracellular dopamine determined by microdialysis in awake squirrel monkeys","volume":"148","author":"Czoty","year":"2000","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.bcp.2007.08.007_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10799898109038802","article-title":"Binding of [3H]cocaine in mouse brain: kinetics and saturability","volume":"2","author":"Reith","year":"1981","journal-title":"J Recept Res"},{"key":"10.1016\/j.bcp.2007.08.007_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004850-199010000-00001","article-title":"A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjects","volume":"5","author":"S\u00f6gaard","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.bcp.2007.08.007_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-3565(24)35321-2","article-title":"Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey","volume":"292","author":"Howell","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.bcp.2007.08.007_bib37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)29344-7","article-title":"The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates","volume":"298","author":"Howell","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s002130000616","article-title":"Further studies of the reinforcing effects of benztropine analogs in Rhesus monkeys","volume":"154","author":"Woolverton","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"issue":"2","key":"10.1016\/j.bcp.2007.08.007_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF02245524","article-title":"Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats","volume":"111","author":"Roberts","year":"1993","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.bcp.2007.08.007_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0376-8716(93)90031-K","article-title":"Effects of GBR 12909 and cocaine on cocaine-maintained behavior in Rhesus monkeys","volume":"33","author":"Skjoldager","year":"1993","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02246278","article-title":"Effects of drug history on the acquisition of responding maintained by GBR 12909 in Rhesus monkeys","volume":"123","author":"Wojnicki","year":"1996","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.bcp.2007.08.007_bib43","first-page":"150","article-title":"Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys","volume":"251","author":"Bergman","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.007_bib44","first-page":"312","article-title":"Pharmacological characterization of the discriminative stimulus effects of cocaine in Rhesus monkeys","volume":"254","author":"Kleven","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.007_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02244175","article-title":"Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat","volume":"104","author":"Cunningham","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2007.08.007_bib46","first-page":"626","article-title":"Pharmacological characterization of the discriminative-stimulus effects of GBR 12909","volume":"258","author":"Melia","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.007_bib47","first-page":"178","article-title":"Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey","volume":"258","author":"Howell","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.007_bib48","first-page":"1041","article-title":"Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine","volume":"270","author":"Terry","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0091-3057(94)00438-O","article-title":"Effects of monoamine reuptake inhibitors on cocaine self-administration in rats","volume":"51","author":"Tella","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.007_bib50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1037\/1064-1297.3.3.219","article-title":"Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding. I. Dependence on unit dose of cocaine","volume":"3","author":"Glowa","year":"1995","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1037\/1064-1297.8.4.539","article-title":"Response requirements and unit dose modify the effects of GBR 12909 on cocaine-maintained behavior","volume":"8","author":"Stafford","year":"2000","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.bcp.2007.08.007_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1098-2396(199904)32:1<44::AID-SYN6>3.0.CO;2-9","article-title":"Doses of GBR12909 which suppress cocaine self-administration in non-human primates substantially occupy DA transporters as measured by [11C]WIN35,428 PET scans","volume":"32","author":"Villemagne","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.bcp.2007.08.007_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<49::AID-SYN6>3.0.CO;2-K","article-title":"RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporter","volume":"30","author":"Dworkin","year":"1998","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/syn.10018","article-title":"Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in Rhesus monkeys","volume":"43","author":"Wilcox","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.bcp.2007.08.007_bib55","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/386827a0","article-title":"Relationship between subjective effects of cocaine and dopamine transporter occupancy","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2007.08.007_bib56","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1523\/JNEUROSCI.16-23-07416.1996","article-title":"Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system","volume":"16","author":"Tella","year":"1996","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.bcp.2007.08.007_bib57","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/PL00005091","article-title":"Chronic administration of the selective dopamine uptake inhibitor GBR 12,909, but not cocaine, produces marked decreases in dopamine transporter density","volume":"356","author":"Kunko","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2007.08.007_bib58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-4328(98)00104-1","article-title":"Continuous infusion of selective dopamine uptake inhibitors or cocaine produces time-dependent changes in rat locomotor activity","volume":"99","author":"Izenwasser","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bcp.2007.08.007_bib59","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1021\/jm960551t","article-title":"Sustained decrease in cocaine-maintained responding in Rhesus monkeys with 1-[2-]bis(4-fluorophenyl)methoxy[ethyl]-4-(3-hydroxy-3-phenylprop yl)piperaziny] decanoate, a long-acting ester derivative of GBR 12909","volume":"39","author":"Glowa","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2007.08.007_bib60","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1021\/jm990291q","article-title":"Oxygenated analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-bis-(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperaz ines (GBR12935 and GBR12909) as potential extended-action cocaine-abuse therapeutic agents","volume":"42","author":"Lewis","year":"1999","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bcp.2007.08.007_bib61","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/jm010430f","volume":"45","author":"Hsin","year":"2002","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bcp.2007.08.007_bib62","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0960-894X(02)00940-X","article-title":"Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents","volume":"13","author":"Hsin","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"1 Suppl","key":"10.1016\/j.bcp.2007.08.007_bib63","first-page":"24S","article-title":"Depot neuroleptics: side effects and safety","volume":"6","author":"Marder","year":"1986","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2007.08.007_bib64","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1124\/jpet.301.3.1190","article-title":"Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate","volume":"301","author":"Baumann","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2007.08.007_bib65","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2002.tb04154.x","article-title":"Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence","volume":"965","author":"Baumann","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.bcp.2007.08.007_bib66","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.162.8.1432","article-title":"Medication development for addictive disorders: the state of the science","volume":"162","author":"Vocci","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.bcp.2007.08.007_bib67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/108705710100600506","article-title":"Development and evaluation of high throughput functional assay methods for HERG potassium channel","volume":"6","author":"Tang","year":"2001","journal-title":"J Biomol Screen"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib68","first-page":"66","article-title":"Catecholamine uptake by synaptosomes from rat brain. Structure\u2013activity relationships of drugs with differential effects on dopamine and norepinephrine neurons","volume":"7","author":"Horn","year":"1971","journal-title":"Mol Pharmacol"},{"issue":"15","key":"10.1016\/j.bcp.2007.08.007_bib69","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1021\/jm00041a002","article-title":"Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles","volume":"37","author":"Newman","year":"1994","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/0929867305666220314215936","article-title":"Novel benztropine [3\u03b1-(diphenylmethoxy)tropane] analogs as probes for the dopamine transporter","volume":"5","author":"Newman","year":"1998","journal-title":"Curr Med Chem"},{"issue":"20","key":"10.1016\/j.bcp.2007.08.007_bib71","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1021\/jm00020a006","article-title":"Novel 4\u2032-substituted and 4\u2032,4\u2033-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors","volume":"38","author":"Newman","year":"1995","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bcp.2007.08.007_bib72","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1021\/jm950782k","article-title":"3\u2032-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4\u2032-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile","volume":"40","author":"Kline","year":"1997","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib73","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-3565(24)37956-X","article-title":"Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine","volume":"288","author":"Katz","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib74","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/jpet.106.118067","article-title":"Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats","volume":"321","author":"Tanda","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.bcp.2007.08.007_bib75","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.bmc.2006.01.017","article-title":"Comparative structure\u2013activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors","volume":"14","author":"Kulkarni","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bcp.2007.08.007_bib76","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/jpet.105.090829","article-title":"Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs","volume":"315","author":"Campbell","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"10.1016\/j.bcp.2007.08.007_bib77","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/jm030646c","article-title":"Structure\u2013activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation","volume":"47","author":"Kulkarni","year":"2004","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/jm000417f","article-title":"Structure\u2013activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3\u2032-chloro-, 4\u2032-chloro-, and 4\u2032,4\u2033-dichloro-substituted-diphenyl)methoxytropanes","volume":"44","author":"Newman","year":"2001","journal-title":"J Med Chem"},{"issue":"26","key":"10.1016\/j.bcp.2007.08.007_bib79","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","article-title":"Novel N-substituted 3 alpha-[bis(4\u2032-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter","volume":"40","author":"Agoston","year":"1997","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bcp.2007.08.007_bib80","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1021\/jm990265s","article-title":"Highly selective chiral N-substituted 3alpha-[bis(4\u2032-fluorophenyl)methoxy]tropane analogues for the dopamine transporter: synthesis and comparative molecular field analysis","volume":"43","author":"Robarge","year":"2000","journal-title":"J Med Chem"},{"issue":"21","key":"10.1016\/j.bcp.2007.08.007_bib81","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1021\/jm060762q","article-title":"Structure\u2013activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation","volume":"49","author":"Zou","year":"2006","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bcp.2007.08.007_bib82","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0960-894X(02)00155-5","article-title":"Enantioselective synthesis of S-(+)-2beta-carboalkoxy-3alpha-[bis(4-fluorophenyl)methoxy]tropanes as novel probes for the dopamine transporter","volume":"12","author":"Zou","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"issue":"14","key":"10.1016\/j.bcp.2007.08.007_bib83","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/jm0300375","article-title":"Structure\u2013activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter","volume":"46","author":"Zou","year":"2003","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bcp.2007.08.007_bib84","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0091-3057(96)00441-8","article-title":"Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine","volume":"57","author":"Katz","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2007.08.007_bib85","doi-asserted-by":"crossref","unstructured":"Katz JL, Kopajtic TA, Agoston GE, Newman AH, Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 2004;309(2):650\u201360x.","DOI":"10.1124\/jpet.103.060525"},{"issue":"2","key":"10.1016\/j.bcp.2007.08.007_bib86","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/jpet.104.080465","article-title":"Effects of 4\u2032-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine","volume":"313","author":"Tanda","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.bcp.2007.08.007_bib87","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/jpet.105.084541","article-title":"Place conditioning and locomotor effects of N-substituted, 4\u2032,4\u2033-difluorobenztropine analogs in rats","volume":"313","author":"Li","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.bcp.2007.08.007_bib88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.105.091231","article-title":"Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs","volume":"315","author":"Desai","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib89","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00213-002-1069-3","article-title":"Self-administration of cocaine: scopolamine combinations by Rhesus monkeys","volume":"161","author":"Ranaldi","year":"2002","journal-title":"Psychopharmacology (Berlin)"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib90","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s002130050012","article-title":"3\u2032- and 4\u2032-Chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in Rhesus monkeys","volume":"147","author":"Woolverton","year":"2000","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.bcp.2007.08.007_bib91","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","article-title":"The dopamine hypothesis of the reinforcing properties of cocaine","volume":"14","author":"Kuhar","year":"1991","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1016\/j.bcp.2007.08.007_bib92","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.103.053504","article-title":"Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques","volume":"307","author":"Raje","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.bcp.2007.08.007_bib93","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.tips.2006.10.006","article-title":"Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction","volume":"27","author":"Rothman","year":"2006","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"10.1016\/j.bcp.2007.08.007_bib94","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1021\/jm040190e","article-title":"Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents","volume":"48","author":"Newman","year":"2005","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bcp.2007.08.007_bib95","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002130000667","article-title":"Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents","volume":"154","author":"Katz","year":"2001","journal-title":"Psychopharmacology (Berlin)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295207005448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295207005448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:43:53Z","timestamp":1737359033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295207005448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0006295207005448"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2007.08.007","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}